-
Mashup Score: 0Is 10,000 steps per day the ‘magic number’? A cardiologist weighs in - 9 month(s) ago
ARLINGTON, Texas — Data show that the commonly used metric of 10,000 steps per day is associated with improvements to overall and CV health, but the number likely is an overestimate and benefits vary by age and sex, according to a speaker.The concept of 10,000 steps per day was created by a Japanese marketing company in 1964 to sell a pedometer, called “Manpo-kei,” which
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Is 10,000 steps per day the ‘magic number’? A cardiologist weighs in - 9 month(s) ago
ARLINGTON, Texas — Data show that the commonly used metric of 10,000 steps per day is associated with improvements to overall and CV health, but the number likely is an overestimate and benefits vary by age and sex, according to a speaker.The concept of 10,000 steps per day was created by a Japanese marketing company in 1964 to sell a pedometer, called “Manpo-kei,” which
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Is 10,000 steps per day the ‘magic number’? A cardiologist weighs in - 9 month(s) ago
ARLINGTON, Texas — Data show that the commonly used metric of 10,000 steps per day is associated with improvements to overall and CV health, but the number likely is an overestimate and benefits vary by age and sex, according to a speaker.The concept of 10,000 steps per day was created by a Japanese marketing company in 1964 to sell a pedometer, called “Manpo-kei,” which
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: ‘There is a role for both’ anatomical, functional testing in cardiac diagnosis - 9 month(s) ago
ARLINGTON, Texas — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discusses how anatomical and functional testing both have a role in cardiac diagnosis. Michos, who is associate professor of medicine and director of women’s cardiovascular health research at Johns Hopkins Medicine, participated in a
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Leverage blood donation system to uncover ‘underdiagnosed’ familial hypercholesterolemia - 9 month(s) ago
ARLINGTON, Texas — Familial hypercholesterolemia is common, underdiagnosed and undertreated, and one complementary approach to improve its diagnosis could include leveraging the blood donation system, according to a speaker. It is estimated that about one in 250 people have familial hypercholesterolemia (FH), an autosomal-dominant disorder that is common across race and ethnic groups and is
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? - 9 month(s) ago
Home > CardioNerds > Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? Elevated lipoprotein (a) [Lp(a)] is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), as demonstrated in several epidemiological, genome-wide association, and Mendelian randomization studies (1-3). However, to date, there are no available therapies that lead to a substantial reduction in Lp(a) and no clinical trial data to support that lowering Lp(a) reduces adverse cardiovas
Source: www.docwirenews.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? - 9 month(s) ago
Home > CardioNerds > Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? Elevated lipoprotein (a) [Lp(a)] is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), as demonstrated in several epidemiological, genome-wide association, and Mendelian randomization studies (1-3). However, to date, there are no available therapies that lead to a substantial reduction in Lp(a) and no clinical trial data to support that lowering Lp(a) reduces adverse cardiovas
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Leverage blood donation system to uncover ‘underdiagnosed’ familial hypercholesterolemia - 9 month(s) ago
ARLINGTON, Texas — Familial hypercholesterolemia is common, underdiagnosed and undertreated, and one complementary approach to improve its diagnosis could include leveraging the blood donation system, according to a speaker. It is estimated that about one in 250 people have familial hypercholesterolemia (FH), an autosomal-dominant disorder that is common across race and ethnic groups and is
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Leverage blood donation system to uncover ‘underdiagnosed’ familial hypercholesterolemia - 9 month(s) ago
ARLINGTON, Texas — Familial hypercholesterolemia is common, underdiagnosed and undertreated, and one complementary approach to improve its diagnosis could include leveraging the blood donation system, according to a speaker. It is estimated that about one in 250 people have familial hypercholesterolemia (FH), an autosomal-dominant disorder that is common across race and ethnic groups and is
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Bakris: Take time, follow guidelines for accurate BP measurements - 9 month(s) ago
ARLINGTON, Texas — An accurate BP measurement is essential to properly diagnose and manage hypertension, yet most providers do not have time to follow the guideline-recommended steps, according to a speaker.Clinic or office BP measurements are one of the most common medical procedures; however, many providers do not follow a standardized approach or do not use clinically validated devices,
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
ICYMI: "The media likes to talk about this magic number of 10,000 steps per day," German said. "Interestingly enough, this number came about with no scientific evidence for backing" @ASPCardio #ASPC2023 @DrGermanMD @UChicagoMed #cardiotwitter https://t.co/1eFmxLHSfx